Literature DB >> 23630056

Three-dimensional nuclear telomere architecture changes during endometrial carcinoma development.

Adrian Danescu1, Sandra Herrero Gonzalez, Antonio Di Cristofano, Sabine Mai, Sabine Hombach-Klonisch.   

Abstract

Endometrioid or type-I endometrial carcinoma (EC) develops from hyperproliferative glandular pathologies. Inactivation of the tumor suppressor gene PTEN is frequently associated with type-I EC. Using a previously characterized Pten heterozygous (Pten+/-) mouse model, this study investigates the three-dimensional (3D) telomere profiles during progression from hyperplastic lesions to EC to test the hypothesis that altered 3D telomere profiles can be detected prior to Pten loss in early hyperproliferative lesions. We used immunohistochemistry and 3D-telomere fluorescent in-situ hybridization to investigate Pten expression, telomere length and signal distribution, average number and spatial distribution of telomeres and formation of telomere aggregates in uterine glandular epithelial cells from wildtype and Pten+/- mice. Pten showed nuclear and cytoplasmic localization in WT, predominantly cytoplasmic staining in simple hyperplasia (SH) and was markedly reduced in atypical hyperplasia (AH). Telomere length in glandular epithelial cells does not shorten with age. The average number of telomeres per nucleus was not different in WT and Pten+/- mice indicating the lack of substantial numeric chromosome aberrations during EC development. We observed telomere aggregates in lesions of AH and EC. SH lesions in Pten+/- mice differed from normal glandular epithelium by an increased relative number of shorter telomeres and by a telomere signal distribution indicative of a heterogeneous cell population. Our study revealed that alterations in the nuclear 3D telomere architecture are present in early proliferative lesions of mouse uterine tissues indicative of EC development. The changes in telomere length distribution and nuclear signal distribution precede the loss of Pten.
Copyright © 2013 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23630056      PMCID: PMC5675068          DOI: 10.1002/gcc.22067

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  84 in total

1.  Increased nuclear phosphatase and tensin homologue deleted on chromosome 10 is associated with G0-G1 in MCF-7 cells.

Authors:  Margaret E Ginn-Pease; Charis Eng
Journal:  Cancer Res       Date:  2003-01-15       Impact factor: 12.701

2.  The Stability of Broken Ends of Chromosomes in Zea Mays.

Authors:  B McClintock
Journal:  Genetics       Date:  1941-03       Impact factor: 4.562

3.  Prognostic significance of DNA ploidy in stage I endometrial cancer.

Authors:  Taejong Song; Jeong-Won Lee; Ha-Jeong Kim; Min Kyu Kim; Chel Hun Choi; Tae-Joong Kim; Duk-Soo Bae; Byoung-Gie Kim
Journal:  Gynecol Oncol       Date:  2011-04-13       Impact factor: 5.482

Review 4.  PTEN function in normal and neoplastic growth.

Authors:  Lionel M L Chow; Suzanne J Baker
Journal:  Cancer Lett       Date:  2006-01-18       Impact factor: 8.679

5.  PTEN mutations and microsatellite instability in complex atypical hyperplasia, a precursor lesion to uterine endometrioid carcinoma.

Authors:  R L Levine; C B Cargile; M S Blazes; B van Rees; R J Kurman; L H Ellenson
Journal:  Cancer Res       Date:  1998-08-01       Impact factor: 12.701

Review 6.  Alternative lengthening of telomeres: models, mechanisms and implications.

Authors:  Anthony J Cesare; Roger R Reddel
Journal:  Nat Rev Genet       Date:  2010-03-30       Impact factor: 53.242

7.  Cell cycle-dependent 3D distribution of telomeres and telomere repeat-binding factor 2 (TRF2) in HaCaT and HaCaT-myc cells.

Authors:  Sibylle Ermler; Damir Krunic; Tobias A Knoch; Sharareh Moshir; Sabine Mai; Karin M Greulich-Bode; Petra Boukamp
Journal:  Eur J Cell Biol       Date:  2004-12       Impact factor: 4.492

8.  Akt-mediated phosphorylation and activation of estrogen receptor alpha is required for endometrial neoplastic transformation in Pten+/- mice.

Authors:  Anna Vilgelm; Zenglin Lian; Hong Wang; Stephen L Beauparlant; Andres Klein-Szanto; Lora Hedrick Ellenson; Antonio Di Cristofano
Journal:  Cancer Res       Date:  2006-04-01       Impact factor: 12.701

9.  Pten is essential for embryonic development and tumour suppression.

Authors:  A Di Cristofano; B Pesce; C Cordon-Cardo; P P Pandolfi
Journal:  Nat Genet       Date:  1998-08       Impact factor: 38.330

10.  The tumour suppressor PTEN mediates a negative regulation of the E3 ubiquitin-protein ligase Nedd4.

Authors:  Younghee Ahn; Chae Young Hwang; Seung-Rock Lee; Ki-Sun Kwon; Cheolju Lee
Journal:  Biochem J       Date:  2008-06-01       Impact factor: 3.857

View more
  3 in total

1.  Three-dimensional Nuclear Telomere Organization in Multiple Myeloma.

Authors:  Ludger Klewes; Rhea Vallente; Eric Dupas; Carolin Brand; Dietrich Grün; Amanda Guffei; Chirawadee Sathitruangsak; Julius A Awe; Alexandra Kuzyk; Daniel Lichtensztejn; Pille Tammur; Tiiu Ilus; Anu Tamm; Mari Punab; Morel Rubinger; Adebayo Olujohungbe; Sabine Mai
Journal:  Transl Oncol       Date:  2013-12-01       Impact factor: 4.243

2.  Vorinostat differentially alters 3D nuclear structure of cancer and non-cancerous esophageal cells.

Authors:  Vivek Nandakumar; Nanna Hansen; Honor L Glenn; Jessica H Han; Stephanie Helland; Kathryn Hernandez; Patti Senechal; Roger H Johnson; Kimberly J Bussey; Deirdre R Meldrum
Journal:  Sci Rep       Date:  2016-08-09       Impact factor: 4.379

3.  High Mobility Group A2 protects cancer cells against telomere dysfunction.

Authors:  Suchitra Natarajan; Farhana Begum; Jeonga Gim; Landon Wark; Dana Henderson; James R Davie; Sabine Hombach-Klonisch; Thomas Klonisch
Journal:  Oncotarget       Date:  2016-03-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.